Stuart John Ashman Insider Profile

4 Followers
Stuart John Ashman, Director at SkinBioTherapeutics, holds 281.25K shares in SkinBioTherapeutics (Ticker: GB:SBTX). Most recently, Stuart John Ashman Bought 156,250p shares of SkinBioTherapeutics on Dec 16, 2022 for an estimated value of 25.00K.
tipranks
Stuart John Ashman

Stuart John Ashman
SkinBioTherapeutics (SBTX)
Director

Ranked #20,248 out of 98,834 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

+122.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

£30K
100.00%
A breakdown of Stuart John Ashman's holdings

Insider Roles

SkinBioTherapeutics
(SBTX)
Director
Roles that Stuart John Ashman holds in companies

Most Profitable Insider Trade

Stock:
SkinBioTherapeutics
(SBTX)
Rating:Informative Buy
Date:Oct 14, 2020 - Oct 14, 2021
Return:+245.80%
The most profitable trade made by Stuart John Ashman

Stuart John Ashman's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
SkinBioTherapeutics
Dec 16, 2022
Director
Informative Buy
25.00K
£29.88K
Success Rate for
SBTX
1 out of 2 profitable transactions on
SBTX
50%
Average Return for
SBTX
Average return per transaction on
SBTX
+122.85%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Dec 16, 2022
Informative Buy
£25.00K
-
£16.00
-0.10%
Oct 14, 2020
Informative Buy
£20.00K
-
£16.00
+245.80%
List of latest transactions for each holding click on a transaction to see Stuart John Ashman's performance on stock

Stuart John Ashman insider profile FAQ

What is the percentage of profitable transactions made by Stuart John Ashman?
The percentage of profitable transactions made by Stuart John Ashman is 50%.
    What is the average return per transaction made by Stuart John Ashman?
    The average return per transaction made by Stuart John Ashman is 122.80%.
      What stocks does Stuart John Ashman hold?
      Stuart John Ashman holds: GB:SBTX stocks.
        What was Stuart John Ashman’s latest transaction?
        Stuart John Ashman latest transaction was an Informative Buy of 25.00K.
          What was Stuart John Ashman's most profitable transaction?
          Stuart John Ashman’s most profitable transaction was an Informative Buy of GB:SBTX stock on October 14, 2020. The return on the trade was 245.80%.
            What is Stuart John Ashman's role in SkinBioTherapeutics?
            Stuart John Ashman's role in SkinBioTherapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.